Upcoming Event

Pepper Hamilton's Health Sciences Speaker Series

Thu. October 12, 2017
5:30 pm - 7:00 pm

!Pepper Hamilton, LLP
New York, NY 10018

The Off-Label Debate and FDA's Shifting Outlook

Recent FDA action adds an important new element to the robust legal and policy debates on how drug and device manufacturers communicate with providers and payers. In two recent draft guidances and a First Amendment memorandum, FDA acknowledged a public health need for certain information outside the four corners of the approved product labeling, signaling a new flexibility. But a grey area between "on-label" and "off-label" communications still exists and requires careful navigation.

Please join us for a seminar that will provide an overview of the current enforcement environment and the recent FDA issuances as well as discuss their practical implications for drug and device companies.

Michael A. Schwartz, Partner and co-chair of the Litigation and Dispute Resolution Department, Pepper Hamilton LLP
Erin Colleran, Associate in the Health Sciences Department, Pepper Hamilton LLP

5:30 - 7:00 PM (ET)

There is no cost to attend.

This seminar is approved for one substantive CLE credit in New York.

This event is sponsored by Pepper Hamilton's Health Sciences Department, a team of 110 attorneys who collaborate across disciplines to solve complex legal challenges confronting clients throughout the health sciences spectrum.


Register here